Literature DB >> 10720725

Long term psychiatric and cognitive effects of MDMA use.

P McGuire1.   

Abstract

Clinical case reports suggest that regular MDMA use can be associated with chronic psychiatric symptoms which persist after the cessation of drug use. Neuropsychological comparisons of regular MDMA users and controls also suggest that MDMA use may lead to memory deficits, with other cognitive processes relatively unaffected. This paper reviews these studies and discusses a number of methodological issues that impact on the interpretation of the findings. Methods for examining the biological effects of MDMA use in man are also outlined. Future research should clarify whether MDMA use has long term psychological effects, and if these are related to changes in central serotonergic function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10720725     DOI: 10.1016/s0378-4274(99)00219-2

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  9 in total

Review 1.  Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse.

Authors:  Antonio Verdejo-García; Francisca López-Torrecillas; Carmen Orozco Giménez; Miguel Pérez-García
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

2.  Reduced 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-initiated oxidative DNA damage and neurodegeneration in prostaglandin H synthase-1 knockout mice.

Authors:  Winnie Jeng; Peter G Wells
Journal:  ACS Chem Neurosci       Date:  2010-02-23       Impact factor: 4.418

Review 3.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

Review 4.  Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.

Authors:  João Paulo Capela; Helena Carmo; Fernando Remião; Maria Lourdes Bastos; Andreas Meisel; Félix Carvalho
Journal:  Mol Neurobiol       Date:  2009-04-17       Impact factor: 5.590

5.  Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical Perspective.

Authors:  Kim P C Kuypers; Eef L Theunissen; Janelle H P van Wel; Elizabeth B de Sousa Fernandes Perna; Anke Linssen; Anke Sambeth; Benjamin G Schultz; Johannes G Ramaekers
Journal:  PLoS One       Date:  2016-02-23       Impact factor: 3.240

Review 6.  Substance-Induced Psychoses: An Updated Literature Review.

Authors:  Alessio Fiorentini; Filippo Cantù; Camilla Crisanti; Guido Cereda; Lucio Oldani; Paolo Brambilla
Journal:  Front Psychiatry       Date:  2021-12-23       Impact factor: 4.157

7.  Symptomatological features of patients with and without Ecstasy use during their first psychotic episode.

Authors:  Fabio Rugani; Silvia Bacciardi; Luca Rovai; Matteo Pacini; Angelo Giovanni Icro Maremmani; Joseph Deltito; Liliana Dell'osso; Icro Maremmani
Journal:  Int J Environ Res Public Health       Date:  2012-06-27       Impact factor: 3.390

8.  Use of stimulant substances among university students in tehran: a qualitative study.

Authors:  Afarin Rahimi-Movaghar; Golara Khastoo; Mahdieh Moinolghorabaei; Masud Yunesian; Ahmad-Reza Sadeghi
Journal:  Iran J Psychiatry Behav Sci       Date:  2011

9.  Self-reported PTSD is associated with increased use of MDMA in adolescents with substance use disorders.

Authors:  Lukas Andreas Basedow; Sören Kuitunen-Paul; Melina Felicitas Wiedmann; Veit Roessner; Yulia Golub
Journal:  Eur J Psychotraumatol       Date:  2021-09-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.